Omics are revolutionizing healthcare; it offers a wide range of use cases in fields like oncology and rare diseases. Discover more with our round table with insights from Paris Region top organizations on the subject.
Discover the testimonies form :
- Florence Meyer-Losic, Senior Director Oncology Ipsen
- Alban Lermine Bioinformatics Director SeqOIA – APHP
- Mickael Ménager, Team Director Institut Imagine
- Paul Rinaudo, CEO Adlin Science
- Stéphane Gérart, AI Business Unit Director/CIO Oncodesign
- Vincent Fert, Executive Vice President Immuno Oncology and EU operations Veracyte
